» Articles » PMID: 28885559

A Critical Review on Health Promoting Benefits of Edible Mushrooms Through Gut Microbiota

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2017 Sep 9
PMID 28885559
Citations 76
Authors
Affiliations
Soon will be listed here.
Abstract

Mushrooms have long been used for medicinal and food purposes for over a thousand years, but a complete elucidation of the health-promoting properties of mushrooms through regulating gut microbiota has not yet been fully exploited. Mushrooms comprise a vast, and yet largely untapped, source of powerful new pharmaceutical substances. Mushrooms have been used in health care for treating simple and common diseases, like skin diseases and pandemic diseases like AIDS. This review is aimed at accumulating the health-promoting benefits of edible mushrooms through gut microbiota. Mushrooms are proven to possess anti-allergic, anti-cholesterol, anti-tumor, and anti-cancer properties. Mushrooms are rich in carbohydrates, like chitin, hemicellulose, β and α-glucans, mannans, xylans, and galactans, which make them the right choice for prebiotics. Mushrooms act as a prebiotics to stimulate the growth of gut microbiota, conferring health benefits to the host. In the present review, we have summarized the beneficial activities of various mushrooms on gut microbiota via the inhibition of exogenous pathogens and, thus, improving the host health.

Citing Articles

Effects of Fermented on Intestinal Barrier Integrity and Immunomodulation in a Lipopolysaccharide-Induced Colonic Model.

Kerezoudi E, Saxami G, Zervakis G, Pletsa V, Brummer R, Kyriacou A Biomedicines. 2025; 13(2).

PMID: 40002843 PMC: 11853518. DOI: 10.3390/biomedicines13020430.


Protein Alleviates High-Fat Diet-Induced Hepatic Lipid Accumulation and Oxidative Stress In Vivo.

Lu H, Yang S, Li W, Zheng B, Zeng S, Chen H Foods. 2025; 14(3).

PMID: 39942052 PMC: 11817179. DOI: 10.3390/foods14030459.


Exploring the potential of probiotics in Alzheimer's disease and gut dysbiosis.

S S, L S D, Rajendran P, N H, S A IBRO Neurosci Rep. 2024; 17:441-455.

PMID: 39629018 PMC: 11612366. DOI: 10.1016/j.ibneur.2024.11.004.


Edible mushrooms as an alternative to animal proteins for having a more sustainable diet: a review.

Pashaei K, Irankhah K, Namkhah Z, Sobhani S J Health Popul Nutr. 2024; 43(1):205.

PMID: 39616410 PMC: 11608470. DOI: 10.1186/s41043-024-00701-5.


Metabolite Profiles and Biological Activities of Different Phenotypes of Beech Mushrooms ().

Jeong S, Yeo H, Ha N, Kim K, Seo K, Jin S Foods. 2024; 13(20).

PMID: 39456387 PMC: 11508092. DOI: 10.3390/foods13203325.


References
1.
Goto Y, Ivanov I . Intestinal epithelial cells as mediators of the commensal-host immune crosstalk. Immunol Cell Biol. 2013; 91(3):204-14. PMC: 3969236. DOI: 10.1038/icb.2012.80. View

2.
Huang G, Cai W, Xu B . Vitamin D2, Ergosterol, and Vitamin B2 Content in Commercially Dried Mushrooms Marketed in China and Increased Vitamin D2 Content Following UV-C Irradiation. Int J Vitam Nutr Res. 2016; 87(5-6):1-10. DOI: 10.1024/0300-9831/a000294. View

3.
Kang J, Jang J, Mishra S, Lee H, Nho C, Shin D . Ergosterol peroxide from Chaga mushroom (Inonotus obliquus) exhibits anti-cancer activity by down-regulation of the β-catenin pathway in colorectal cancer. J Ethnopharmacol. 2015; 173:303-12. DOI: 10.1016/j.jep.2015.07.030. View

4.
Zeng Q, Zhou F, Lei L, Chen J, Lu J, Zhou J . Ganoderma lucidum polysaccharides protect fibroblasts against UVB-induced photoaging. Mol Med Rep. 2016; 15(1):111-116. PMC: 5355704. DOI: 10.3892/mmr.2016.6026. View

5.
Lemieszek M, Rzeski W . Anticancer properties of polysaccharides isolated from fungi of the Basidiomycetes class. Contemp Oncol (Pozn). 2013; 16(4):285-9. PMC: 3687424. DOI: 10.5114/wo.2012.30055. View